{
    "2021-07-05": [
        [
            {
                "time": "",
                "original_text": "瑞尔集团“流血”上市：三年亏损超12亿，对赌大限将至 亏损",
                "features": {
                    "keywords": [
                        "瑞尔集团",
                        "流血上市",
                        "亏损",
                        "对赌协议"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "健康服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：全方位盘点上半年医药行业、细分领域、个股风云变幻",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业周报",
                        "盘点",
                        "细分领域",
                        "个股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}